Helicobacter pylori is considered the main etiological agent of gastritis, ulcers, and gastric carcinoma. It colonizes human gastric mucosa quite efficiently. Fifty % of the world population is actually infected. Since H. pylori discovery in 1982, it is well known the sensitivity of several H. pylori strains to a number of antibiotics when these are assayed in vitro. However, eradication therapies with a single antibacterial agent have failed. Recently, triple, quadruple, sequential, concomitant and hybrid therapies which include antibiotics and a proton pump inhibitor show improved eradication rate and low side effects. However, new problems have emerged. Antimicrobial resistance to the common antibiotics used has become a problem in both developed and developing countries. In particular, H. pylori clarithromycin-and metronidazole-resistant strains are a major problem in countries where H. pylori is highly prevalent. Thus, the widespread use of antibiotics is not economically feasible and might increase difficulties in the treatment of H. pylori. At present, there are no vaccines available in the market. As an alternative, effective non-antibiotic compounds should be highly desirable since their use may be safer and suitable to eradicate H. pylori. The first step in this direction has been to study the effect of medicinal herbs and natural products, such as green tea, ginseng, garlic, propolis, and probiotics, then identify their active components such as polyphenols, antioxidants, purify them, and finally test them using in vitro and in vivo H. pylori growth assays. Some of them have been quite effective. The topics related to alternative therapies for H. pylori infections and current status of their use will be discussed in the present review.
Introduction
Although antibiotics are usually effective in the treatment of Helicobacter pylori infection their success is limited. H. pylori causes lifelong chronic gastritis, which can lead to peptic ulcers, mucosa-associated lymphoid tissue (MALT) lymphoma and gastric cancer [1] . In the past, H. pylori infections were associated with eradication rate greater than 80% [2] [3] [4] . However, antibiotic treatments induce resistance mostly due to interruption of treatment doses. Also, antibiotics are expensive and promote adverse side effects.
At present there is no large scale production of an effective vaccine against H. pylori available at the market [5] ; therefore, other alternative approaches such as natural products, the central topic of this review, as well as phage therapies tested on Campylobacter species [6] and phototherapy [7] should be tried.
Active compounds including antioxidants from plants and other H. pylori natural sources and urease inhibitors [8] are valid alternatives to control gastric colonization.
The use of natural products and antioxidants may improve antibiotic treatment efficacy and reduce unwanted side effects. Few reviews are available on this subject [8] [9] [10] .
Natural Tea-Type Infusions

Green Tea
It has been early reported that tea catechins have antibacterial activity against some food-borne pathogens [11] . In addition, a variety of beneficial activities on human health has been described in tea catechins which correspond to almost 15% of green tea referred as dry weight [12] . It has been quite interesting to search for tea catechins antibacterial properties for the eradication of H. pylori. The study of Mabe et al., 2009 [13] has been focused on this aspect. In vitro studies to estimate the Minimal Inhibitory Concentration (MIC) values and the in vivo effects of the gastric mucosal injury were done using the Mongolian gerbil as an animal model and H. pylori ATCC 43504 (10 8 CFU or colony forming unit) as the inoculating strain. They identified four catechins: epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECg, and epigallo-catechin gallate (EGCg), being EGCg the most effective in vitro (MIC range = 1 -64 ug/ml) when assayed on 110 clinical isolates. In contrast, in vivo studies using tea catechins showed antibacterial activity but low eradication rate, ranging 10% -36.4%. It was proposed that pH dependency of catechin antibacterial activity and short gastric transit time of these agents were responsible for producing such low eradication rates. A more recent study on tea polyphenols [14] from 9 tea extracts including 4 different processed tea types (white, green, oolong and black) were tried on H. pylori to evaluate growth inhibition. Aqueous extraction by boiling during 5 min was more effective than 2 min. In this last case, only 2 teas showed inhibition on this bacterium. The inhibition by polyphenols is not due to inhibition of proline oxidation via proline dehydrogenase. In addition, the extracts did not affect the beneficial lactic bacteria. Gallic acid, quercetin, caffeine and tea catechins (catechin, epicatechin, and epigallocatechin), are present in all tea samples. These authors suggested that tea can be used as a cheap dietary com-plement to fighting H. pylori gastric diseases.
Recently, studies using green tea as therapeutic agent showed that using CSA (comparative screening assay), a score reduction higher than 8 × 10⁴ CFU (colony forming unit) was found in more than 60% of the positive strains by green tea (81.5%), which also possess additional beneficial properties, e.g. antioxidant, anti-inflammatory and antitumor activities. Therefore, these plants may have a beneficial use as prophylactic agents against or adjuvants in the therapy of H. pylori infection [15] [16].
Honey and Teas
In a study done by Boyanova et al., (2015) [17] , authors evaluated the influence of dietary and demographic factors and some habits on the prevalence of H. pylori infection in 150 dyspeptic patients examined by endoscopy and urea breath tests. Positivity rate was lower (50.6%) in patients consuming honey ≥1 day weekly compared with the re- 
Propolis
Propolis (bee glue) is a resinous product collected by honeybees from plants. The main sources of propolis are the buds of poplars [18] . If suitable plant sources are not available for honey bees, toxic substances may be included in the propolis. Bee glue contains resins such as flavonoids and derivatives of phenolic acids, wax, essential oils, pollen and organic compounds [19] . Propolis has antimicrobial, antioxidant, anti-inflammatory and anesthetic properties. In addition, synergistic effect with antibacterial agents has been described [20] . Bee glue affects cytoplasmic membrane and bacterial motility [21] . In general, Propolis presents bacteriostatic activity against different bacterial genera but can be bactericidal at higher doses [22] . Brazilian propolis has been described as effective hepatoprotective agent and having anti-H. pylori activity. Recently, Bulgarian propolis was tested in vitro on several H. pylori strains, using different methods [15] .
They used agar-well diffusion, agar dilution and disc diffusion methods to evaluate the antimicrobial activity of a 30% ethanolic extract of Bulgarian propolis. These authors found a strong dose-dependent activity against most of H. pylori strains tested. Although the in vitro effect is promising, further pharmacological and clinical trials are needed to confirm its in vivo activity. Propolis and Zingiber officinalis (ginger root tea) extracts have demonstrated to be specific for H. pylori strains, and also presenting anti-inflammatory, antioxidant and antitumoral activities when employed in traditional medicine [23] . Nostro group evaluated the combined effect of propolis and clarithromycin on H. pylori isolates characterized as clarithromycin susceptible and carrying the cagA gene. They found that combinations of propolis extracts and clarithromycin, as well as, Z. officinalis extracts and clarithromycin presented improved properties to inhibit H. pylori growth. Interestingly, the susceptibility to those combinations was independent of the H. pylori clarithromycin status. These data showed that these combinations have the potential to control H. pylori-associated diseases in patients colonized with clarithromycin resistant strains. Cui et al., (2013) [24] demonstrated that caffeic acid phenethyl ester (CAPE) showed strong inhibitory activity against H. pylori peptide deformylase (Hp PDF), which also may account for the anti-H. pylori activity of propolis. Moreover, the structure of CAPE is different from the majority of known PDF inhibitors, which are mainly pseudopeptides. CAPE binds at the enzyme active site region without interaction with the catalytic Co 2+ , which may decrease the interaction between CAPE and other metalloproteins in the human body and hence reduce the possible adverse effect. A recent study [25] including 15 different ethanolic propolis extracts (EPEs) to treat H. pylori was performed. The anti-H. pylori and anti-urease activities were evaluated. The total phenolic contents and total flavonoid contents of the EPE were also measured. The agar-well diffusion assay was carried out on H. pylori strain J99 and the inhibition zones were measured and compared with standards. All propolis extracts showed high inhibition on H. pylori J99, with inhibition halo a diameter ranging from 31.0 to 47.0 mm. H. pylori urease inhibitory activity was measured using the phenol-hypochlorite assay. All EPEs showed significant inhibition of the enzyme, with 50% inhibition concentrations (IC50 values) ranging from 0.260 to 1.525 mg/ml. The degree of inhibition was related to the phenolic content of the EPE. The authors concluded that propolis extract was found to be a good inhibitor that can be used in H. pylori treatment to improve human health [25] .
Ginseng
Early, in 1987, studies on Ginseng consumption have been reported indicating a reduction of the risk of cancer in diverse organs, including the lip, oral cavity, pharynx, larynx, esophagus, lung, liver, pancreas, ovary, colon, rectum, and stomach, as demonstrated in clinical and epidemiological studies [26] [27] . Based on these findings, Panax ginseng has been classified as a "non-organ-specific cancer preventive". However, since the early development and uses of traditional medicinal herbs has been questioned and purified compounds and exact mode of action are required to convince skeptical people. The use of panaceic compounds such as protopanaxatriol has been a prime issue discussed in terms of complementary and alternative medicine.
A study of Bae et al., (2001) [28] showed the inhibitory effect of polyacetylenes and protopanaxatriol, compounds isolated from heated Ginseng extracts (family Araliaceae, Pana) on H. pylori growth by in vitro assays. Regarding particular Ginseng compounds tested, panaxytriol, a fatty alcohol, was extremely effective in inhibiting H. pylori growth with a MIC value of 50 µg/ml. In addition, Ginsenoside Rh1 and protopanaxatriol (a tetracycle triterpenoid saponin), weakly inhibited H+/K+ ATPase from rat sto- [40] .
Moreover, gastric juice enhances the antimicrobial activity of garlic constituents [41] .
Allicin was identified as the main antimicrobial compound provided by garlic. Allicin is formed catalytically when garlic cloves are crushed and the enzyme allicinase of the bundle sheath cells meets its substrate, allicin, which is released from mesophyll cells [40] . Most common commercial preparations of garlic are garlic powder (GP) and garlic oil (GO). GP is prepared from sliced, dried and pulverized garlic cloves which form allicin after addition of water. GO is produced by heating of crushed garlic cloves to 100˚C and collection of this vapor is recovered as a distillate [42] . This process is equivalent to cooking crushed garlic and allicin converts into diallyl sulfide (DADS) and other derivatives.
A study of O'Gara et al., (2000) [43] revealed that anti-H. pylori activity was considerably greater for the GO (MIC values ranged 8-62-fold lower) than GP and large differences were detected among diallyl derivatives. Allicin, the only diallyl compound and major thiosulfinate formed from GP were more inhibitory (MIC range 6 -12 µg/ml) than any DAS (Diallyl sulfide), except DATTS (Diallyl thiosulfinates) (MIC range 3 -6 µg/ml). Following H. pylori time course viability it was noted that after 1-hour exposures to 129 µg/ml of GO, H. pylori motility was greatly reduced, bacterial clumping increased, and 25% -50% of cells presented morphology changes to coccoid forms. By 6 hours most cells were coccoids. These cells are no longer viable.
The common use of dietary garlic to fight infections and the medicinal use of GO to treat various diseases [40] suggest that the systemic distribution of garlic compounds is quite efficient. GO sulfides are easily absorbed. Some of them such as DADS (Diallyl disulfides) have significant half-lives in blood and the allyl methyl sulfide [44] , a major allicin metabolite derivative, is persistent in a way that it can be detected on the breath.
In the search for the target of these garlic compounds Chung et al., (1998) [45] described the reduction in the activity of arylamine N-acetyl transferase (NAT) in H. pylori isolated from ulcer patients when treated with garlic compounds. The NAT enzyme was assayed using p-aminobenzoic acid (PABA) and 2-aminofluorene (2-AF) as substrates for acetylating reactions. Chung, (1999) [46] , presented two assay systems: one with cellular cytosol and the other with intact cells as sources of enzymatic activity. The results indicated that NAT activity was decreased in those cases with H. pylori cytosols or cell suspensions were specifically treated with increased amounts of DAD or DADS.
The data also indicated that both compounds decreased apparent Km and Vmax values of H. pylori NAT enzyme in both systems assayed. This was the first report that confirmed that garlic components can affect H. pylori growth and NAT activity.
Recently, Tang et al., (2014) [39] investigated the prevalence of H. pylori infection and its risk factors in Chengdu, China. The participants who ate raw garlic had a lower level of H. pylori infection than those who did not eat raw garlic (52.6% vs. 67.9%, P < 0.05), indicating that apparently raw garlic reduced the infection. A direct application of garlic extracts with no further purification can be accomplished for the treatment of H. pylori infection. In the future, this will require a development of new fields of research.
Other Herbs and Species Extracts
As a result of the use of diverse antibiotic treatments and better hygienic conditions, 
Cinnamon Extracts
Ethanol and methylene chloride (MC) extracts of cinnamon were studied to compare their in vitro effect on H. pylori growth and urease activity [48] . MC extract inhibited H. pylori growth at a concentration range of common antibiotics, while ethanol extract counteracted its urease activity. Complete inhibition was achieved by 50 µg/ml in solid media and 15 µg/ml in liquid media. Cinnamon extracts were more effective to inhibit free urease than urease bound to whole cells. Studies have been done to evaluate the effect of an ethanolic extract of cinnamon in a group of 15 patients infected with H. pylori [49] . Eight patients were given 40 mg of ethanolic extract twice daily for 4 weeks and 7 received placebo. The amount of colonization was similar as estimated by the 13 C urea breath test before and after therapy. It was concluded that a daily dose of 80 mg of cin-namon extract as the single agent was ineffective to eradicate H. pylori. A recent study [50] reported cinnamaldehyde (CM) as a major active constituent of cinnamon. Pre-incubation of cells (AGS/MKN-45) with CM significantly inhibited the IL-8 secretion/expression from H. pylori-infected cells (p < 0.01). In addition, CM suppressed H. pylori-induced NF-κB activation and prevented degradation of inhibitor (I)-κB. This study provides evidence that the anti-inflammatory effect of Cinnamomum cassia on H. pylori-infected gastric cells is due to blockage of the NF-κB pathway by cinnamaldehyde. This agent can be considered as a potential candidate for in vivo and clinical studies against H. pylori-related gastric pathogenic processes. Moreover, the combination of cinnamon extract with other antimicrobial agents at higher doses should be explored.
Berry Extracts Berry Extracts
Chatterjee et al., (2004) [51] described the in vitro inhibitory effect of various berry extracts on the growth of H. pylori. Also, berry extracts produced enhanced susceptibility to clarithromycin. Bacterial suspensions were incubated for 18 hours with single extracts of raspberry, strawberry, cranberry, elderberry, blueberry and bilberry and with Optiberry, which is a mixture of these 6 types of berries, at 0.25% -1% concentrations. H. pylori growth was confirmed by CLO test (rapid urease test). All berry extracts significantly inhibited (p < 0.05) H. pylori growth, increasing susceptibility to clarithromycin (15 µg/ml), in particular, Optiberry, that showed maximal effects.
The combined use of silver nanoparticles (AgNps) and methanol extract of Solanum xanthocarpum, commonly known as yellow-berried nightshade effectively inhibited the growth of H. pylori, indicating a stronger anti-H. pylori activity than that of AgNO3 or metronidazole, being almost equally potent to tetracycline but less potent than amoxicillin and clarithromycin. Yellow-berried nightshade is a prickly plant, which grows wild in different regions of the Indo-Pakistan subcontinent has been tested and compare with typical antibiotics. AgNps (silver nanoparticles) sample and S1-extract with AgNps were found equally efficient when tested against the antibiotic-resistant or antibiotic-susceptible H. pylori strains. The anti-H. pylori activity was measured by the agar dilution method. The MIC90 was determined as standard procedure. The s1 extract contained typical Ag nanoparticles (20 ml 1mM AgNO3 mixed with 10 ml of S. xanthocarpum methanolic extract. Other S. xanthocarpum extracts were prepared to vary the amount of extract. In addition, after the H. pylori urease inhibitory assay, S1
exhibited a significant inhibition [52] .
Plant Extracts from Ancestral Traditional Medicine
There are several studies done on different medicinal plants searching for anti-H. pylori activity described in differents countries and regions around the globe, such as Mali, Nigeria, South Africa (in Africa), Iran, Pakistan China Taiwan, Korea (in Asia), Southern Chios (Greek Island, Europe), Ecuador, Peru, Brazil, The Amazon (in South America). Table 1 shows a list of them. In some cases extracts obtained with different organic solvent have been tested. In some others the chemical nature of the compound having this inhibitory has been identified. In few cases the target for these antimicrobials has been established. Some examples are cited below.
A group of 17 plants as ethanolic or aqueous extracts was studied as containing active agents for the treatment of H. pylori infections [53] . A standard laboratory H. pylori strain and 11 clinical isolates were tested by using disk diffusion test and MIC assay on solid medium. Inhibitory activity was detected in most of the tested plants. MIC values of ethanolic extracts were from 2 to 4-fold lower concentrations than the aqueous ones. Particularly, ethanolic extracts of Cuminum cyminum and Propolis re-vealed MIC90 values of 75 µg/ml, that represent significant in vitro effect of plant extracts that may contribute to the development of new and safe agents to control H. pylori infections.
At Mali, Western Africa, traditional medicine uses the plant Pteleopsis suberosa for the treatment of gastric and duodenal ulcers. Germano et al., (1998) [54] evaluated extracts of stem bark of this plant as anti-ulcer and antibacterial activity against a laboratory H. pylori strain and several clinical isolates. The decoction, the traditional form of administration of the drug in Mali and the methanolic extract were active against all strain tested. MIC ranged from 62.5 to 500 µg/ml of the decoction and 31.25 to 250 µg/ml of the methanolic extract. These results suggest that this plant may be a source of the active compounds with therapeutic potential against diseases associated with H. pylori infections.
A methanolic extract from Allium ascalonicum Linn (Liliaceae) leaves has been tried in vitro on five strains of H. pylori by the agar diffusion method [55] . This plant contains alkaloids, cardiac glycosides, and saponins, as detected by phytochemical screening. The MIC of the extract against tested strains ranged from 6.25 to 12.5 µg/ml. In addition, it was found that increasing concentrations of the extract decreased the urease activity of these strains. The results of this work suggest that Allium ascalonicum has some useful components to fight H. pylori infections.
Among several other plants studied, thyme, a low grower herb, with tiny white flowers lasting for several weeks each summer, was used as aqueous extract and resulted effective against H. pylori [70] . Since aqueous extract of thyme is easy to produce and consume, this preparation was further investigated. Compared to other antibacterial agents, thyme extract had significant inhibitory effects on H. pylori growth and urease activity. These findings wait for further validation through clinical studies.
A study of Wang et al., (1998) [71] described the effect of aloe-emodin on the NAT activity of H. pylori strains collected from patients with peptic ulcer. Assays using cytosols or suspensions of intact H. pylori cells showed that there was a decrease of bacterial NAT activity associated with an increase in aloe-emodin. Also, inhibition of H. pylori growth was aloe-emodin dose-dependent.
Another work was done by Malekzadeh et al., (2001) [57] found that water extracts of black myrobalan (Terminalia chebula Retz) had antimicrobial activity against H. pylori (MIC = 125 µg/ml and MBC (Minimum Bactericidal Concentration) = 150 µg/ml. This extract was active even after autoclaving for 30 min at 121˚C. In addition, this extract at the concentration of 1-2,5 mg/ml was able to inhibit urease activity of H. pylori, suggesting a possible therapeutic application.
Bae et al. (1998) [72] analyzed 5 plants as a source of antimicrobial activities against H. pylori: Coptidisjaponica (rhizoma), Eugenia caryophyllata (flower), Rheum palmatum (rhizoma), Magnolia officinalis (cortex) and Gallarhois Rusjavanica. All of them inhibited H. pylori growth but only Gallarhois extract showed inhibitory effect on H. pylori urease.
Grapefruit (Aristotochia pucinervis) methanolic and hexane extract fractions ob-tained from rhizome and leaves were effective as H. pylori growth inhibitors [73] . The A.pucinervis leaf hexane fraction (APLH) showed higher activity (MIC = 4 µg/ml) than the rhizome hexane fraction (APRH, MIC = 16 µg/ml Ranilla et al (2012) [62] have studied water extracts from an Amazon medicinal plant called "Chancapiedra" (Phyllanthus niruri L.) from Ecuador and Peru. These extracts displayed proficient antimicrobial activity against H. pylori whereas different strains of lactic acid bacteria such as Lactobacillus acidophilus, Lactobacillus casei and Lactobacillus plantarum were not inhibited. H. pylori were inhibited by water extracts collected from plants of both countries in a dose-dependent manner. Both extracts contained ellagic acid and hydroxycinnamic acid derivatives and displayed high free radical scavenging linked-antioxidant activities. However, gallic acid was detected only in the Ecuadorian extract. Regarding the Chancapiedra mechanism of action against H. pylori it has been proposed that inhibition may not involve inhibition of oxidative phosphorylation by proline dehydrogenase associated with simple mono-phenolics but rather involve ellagitannins or other non-phenolic compounds through a yet unknown mechanism. The advantage of Chancapiedra as an inhibitor of H. pylori growth is that this extract does not affect beneficial lactic acid bacteria.
Guanandi (Calophyllum brasiliense Camb), is a large tree belonging to Clusiaceae family widely distributed in Latin America that grows in tropical and swampy areas in Brazil. From its stem bark produces an exudate similar to latex, which has been used in folk medicine for treatment of gastric ulcer among other disease and symptoms [75] [76]. Several compounds have been obtained from its stem bark, such as chromanone acids. In order to evaluate its anti-ulcer activity and probable mechanism(s) of action, a fraction with a mixture of chromanone acids (BI), collected after purification by col-umn chromatography of a stem bark hexane extract of Calophyllum brasiliense (HECb) has been tested, using experimental in vitro and in vivo models [63] . The ulcer was induced in mice by oral administration of ethanol (75%, v/v) and indomethacin (50 mg/kg). For evaluation of a hexane fraction of an extract of the stem bark of Calophyllum brasiliense containing a mixture of chromanone acids (BI) on nitric oxide (NO) level, the ulcer was induced by ethanol in N-Nitro L-Arginine Methyl Ester (L-NAME) pretreated animals. Anti-H. pylori activity was tested in disk diffusion and broth microdilution in vitro assays, usingcagA+ and vacA+H. pylori strains. BI fractions avoided gastric ulceration caused by ethanol and indomethacin treatments. The gastroprotective mechanism of BI in ethanol-induced ulcer was partly due to reduction of Malondialdehyde (MDA) and Catalase (CAT) levels in the gastric tissue. BI did not affect glutathione (GSH) levels and its gastroprotective effect was not reversed by pretreatment with L-NAME. BI showed anti-H. pylori activity in both assays. The results indicated that BI is partly responsible for the anti-ulcer and anti-H. pylori effects of HECb.
A resin known as mastic, was obtained from Pistacia lentiscus (L.) var. chia (Duham), an evergreen shrub belonging to the family Anacardiaceae and uniquely cultivated in Southern Chios, a Greek island [77] . It has been used for more than 2500 years in traditional Greek medicine to treat gastralgia and peptic ulcers, while the effects of [64] . A time-kill study was also accomplished using H. pylori ATCC 43579. It was found that E.torelliana extract inhibited H. pylori growth in all tested cases, and the addition of one identified active compounds (a substituted pyrenyl ester) enhanced the activity of clarithromycin. When mixed, the MIC values of each one were reduced twofold, from 0.125 to 0.0625 µg/ml in clarithromycin and from> 100 to 50 µg/ml the pyrenyl ester. After 3 hours of exposure to a combination of 0.25 µg/ml clarithromycin and 100 µg/ml of the pyrenyl ester reduced 100% growth of H. pylori ATCC 43579. This demonstrates that sometimes combination of plant compounds and antibiotics may be quite effective for treatment of H. pylori infections.
Ferreira et al., (2012) [78] reported in vitro antimicrobial studies with different crude extracts obtained from 2 plants: Cistus ladanifer, a flowering plant in the Cistaceae fam-ily and Arbutus unedo (strawberry tree), a tree with edible fruits. Both species are native from Western Mediterranean region. Extracts were prepared in a different way. The antimicrobial activities were tested on reference strains, including three Gram-positive, five Gram-negative and three yeasts, and on several clinical isolates of H. pylori and methicillin-resistant Staphylococcus aureus strains. All extracts presented in vitro activity against the Gram-positive bacteria, Klebsiella pneumoniae, Candida tropicalis and H. pylori, being particularly effective on the last one.
Njume et al., (2011) [65] have studied the susceptibility of 32 clinical strains of H. pylori and a reference strain against 5 solvent extracts of Combretum molle, a plant widely used for the treatment of gastric ulcers and other stomach-related morbidities in South Africa. The extracts were screened for activity by the agar-well diffusion method, and the most active were tested against the same strains by micro-broth dilution and time-kill assays. Metronidazole and amoxicillin were included as positive controls. All extracts showed anti-H. pylori activity with halo diameters of inhibition between 0 and 38 mm. The most active extract against H. pylori was the acetone extract, to which 87.5% of the clinical isolates were susceptible. The MIC90 values for this extract ranged from 1.25 to 5.0 mg/ml while those for amoxicillin and metronidazole ranged from 0.001 to 0.94 mg/ml and from 0.004 to 5.0 mg/ml respectively. The acetone extract was highly bactericidal at a range of 2.5 -5.0 mg/ml, with the total elimination of the bacteria in 24 hours. Its inhibitory activity was better than that of metronidazole (p < 0.05).
Another example of plant product with antimicrobial activity against H. pylori is Urushiol [66] . This is one of the main components of the lacquer tree, which has been used as a folk remedy for the relief of abdominal pain in Korea. Monomers and tetramers of polymeric urushiol were used. In the in vitro study, pH-and concentration-dependent antibacterial activity of the urushiol against H. pylori was investigated. In addition, the serial morphological effects of urushiol on H. pylori were examined by electron microscopy. Ananimal study was performed to assess the safety, eradication rate, and the effect of urushiol on gastritis. The MIC of the extract against strains ranged 0.064 -0.256 mg/ml. Urushiol caused separation of the membrane and lysis of H. pylori within 10 minutes. Urushiol (0.128 mg/ml given by 7 days did not cause complications on mice. The eradication rates were 33% in the urushiol monotherapy, 75% in the common triple therapy (omeprazole + clarithromycin + metronidazole), and 100% in the urushiol + triple therapy, respectively. H. pylori-induced gastritis was not changed by urushiol but reduced by eradication. Expression of interleukin-1β in the gastric tissue was significantly increased by H. pylori infection and reduced by the urushiol and H. pylori eradication (p = 0.014). The urushiol has an antibacterial effect against H. pylori infection and may be used for H. pylori eradication.
There are a number of plants in Pakistan such as Acacia nilotica (L.), Delile, Calotropis procera (Aiton), T.T (Aiton), Adhato davasica Nees, Fagonia arabica and Casuarina equisetifolia L, which have been traditionally used in folk medicine. A recent study carried out by Amin et al., (2013) [67] tested the presence of anti-H. pylori activity and urease inhibition by different extracts of these plants, native from Soon Valley, Punjab, on 34 clinical isolates and 2 reference strains. Methanol and acetone extracts from Acacia nilotica and Calotropis procera showed stronger anti-H. pylori activity than metronidazole but were less efficient than amoxicillin and clarithromycin. Both extracts also showed significant inhibition of urease activity. Other extracts displayed lower activity that other used antibiotics. A competitive inhibition mechanism for urease by Acacianilotica extract was suggested.
Another plant, Geranium wilfordii Maxim, widely used in Chinese Herbal Medicine to treat gastrointestinal disorders has been studied by Zhang et al., (2013) [68] . An ethanol extract was further fractionated by chloroform, ethyl acetate, and n-butyl alcohol extractions. Using a reference strain and 5 clinical isolates strong inhibition of H. pylori growth was detected in the ethanol and ethyl acetate fraction and corilagin and 1, 2, 3, 6 tetra-O-galloyl-β-D-glucose were identified. These compounds displayed MIC values of 4 and 8 mg/ml respectively.
A recent study has been done to evaluate the anti-H. pylori activity of Alchemilla glabra Neygenf (Alchemilla), A. monticola Opiz (Plicatae S.E. Fröhner), A. fissa Günther and Schummel (Calycinae Buser) and A. viridiflora Rothm (Calycinae), and identified ellagic acid and quercetin-3-O-β-glucoside. Anti-H. pylori activity was tested against ten clinical isolates and one reference strain (ATCC 43504). The methanol extracts were more active than the dichloromethane and cyclohexane extracts. The ranges of concentrations were between 4 μg/ml for methanol extracts of A. viridiflora, A. glabra and A. monticola, and 256 μg/ml for cyclohexane extracts of A. viridiflora, A. glabra and A. fissa. The best inhibitory activity was obtained with A. monticola extracts.
No significant difference was found in the ellagic acid contents of the methanol extracts of the Alchemilla species (0.2 -0.3 mg/ml), and anti-H. pylori activity was similar (4 -32 μg/ml). Ellagic acid exhibited strong activity at very low concentrations (0.125-0.5 μg/ml), while the second identified compound, quercetin-3-O-β-D-glucoside, was also very active but at the concentration of 2 -16 μg/ml [79] .
A recent study [69] [83] [84], multidrug-resistant Salmonella typhi [85] and against food-borne pathogens and spoilage bacteria displaying antidiarrheal and tanicidal activities. Also, a recent review reported anti-inflammatory, antioxidant and anticancer effects [86] .
The only human trials examining the antibacterial properties of pomegranate extracts have focused on oral bacteria [87] [88] [89] [90] . However, several in vitro assays demonstrated its bactericidal activity against several highly pathogenic and sometimes antibiotic-resistant microorganisms. Brazilian researchers evaluated the synergistic effect of a P. granatum methanolic extract with five antibiotics on 30 clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus [84] . The antibiotics tested were chloramphenicol, gentamicin, ampicillin, tetracycline, and oxacillin. Although synergistic activity between the pomegranate extract and all five antibiotics was noted in the S. aureus isolates, synergy with ampicillin was most pronounced. A combination of the two increased the lag time to bacterial growth by three hours (over that ampicillin alone) and was also bactericidal as evidenced by a 72.5-percent reduction in methicillin-sensitive organisms and a 99.9-percent reduction in MRSA. Based on earlier research [91] and the results of the above studies, ellagitannin and punicalagin are thought to be the primary constituents responsible for the observed antibacterial effects. Ellagitannins, ellagic acid, and punicalagin have been described as its antimicrobial bioactive compounds among others [86] .
During recent years, a problem due to antibiotic resistance by bacteria has emerged and requires the search for novel compounds to be used as therapy agents. Recently, Hajimahmoodi et al., (2011) [92] 
Purified Compounds (Phytodrugs)
Vitamins and Antioxidants
N-acetyltransferase enzyme (NAT) is a ubiquitous enzyme found in bacteria, fungi and protozoa, mammals and even common fruits and vegetables. This NAT activity has been demonstrated to be present in some human gastrointestinal flora [94] . Since H. pylori have been associated with gastric cancer it would be to evaluate the effect of some vitamins on the NAT activity detected in this bacterium.
In this context, the effect of vitamin E on the arylamine N-acetyltransferase activity in H. pylori strains isolated from patients with peptic ulcers has been studied. Chung (1999) [46] described that treatment of H. pylori with different concentrations of vitamin E showed different percentages of 2-AF (2-amino fluorene) acetylation indicating that an increased NAT activity associated with increased levels of vitamin E in H. pylori cytosol as well as intact bacteria. It was found that apparent values of Km and Vmax of NAT enzyme were increased when vitamin E was added to the mixtures of 2-AF and PABA acetylation, respectively. This was the first report that antioxidants such as vitamin E can promote H. pylori NAT activity. In addition, a study of Chuang et al., (2002) [95] described that vitamins C and E as supplements to normal triple therapy may reduce eradication rate of metronidazole-susceptible H. pylori as well as gastric inflammation in infected patients. A group of infected patients treated with lansoprazole, amoxicillin, metronidazole and vitamin E (200 mg) and vitamin C (200 mg) twice daily for one week following by only vitamins (same doses) once daily for 6 consecutive weeks revealed that H. pylori eradication tested 8 weeks post-treatment was not different compared to the treatment without vitamins. In conclusion, adding vitamin C and E to the triple therapy do not improve H. pylori eradication rate and gastric inflammation.
Another study reported by Chatterjee et al., (2003) [96] described the effect of two anti-oxidants on the growth of H. pylori: Garcinol and Protokin, a commercial compound (InterHealth Nutraceuticals, CA, USA) containing 50% of resveratrol. Garcinol resulted in a bactericidal agent more effective than resveratrol when tested in vitro on H. pylori ATCC 49503.
Phytochemicals as Antioxidants
Several compounds present in food extracts have been used to reduce the risk of damage due to H. pylori infections. Epigallocatechin-3-gallate present in green tea inhibited the urease enzyme of these bacteria in vitro and also in vivo, after infection of Mongolian gerbils [97] . Sulforaphane (SFN), which is present in large amounts in broccoli sprouts presented an anti-bacterial activity on H. pylori through a still unknown mechanism, producing a chemoprotective effect and reducing bacterial colonization in H. pylori infected mice and also humans [98] [99] . Since the list of these compounds is extent, we will revise few of these cases only ( Table 2) Although the results seem relevant, the evidence for the use of broccoli, GRA, and SFN in humans is limited. Additional intervention studies will be needed to evaluate outcomes more consistently with solid conclusions.
Flavonoids and Polyphenols
The inhibitory effect of flavonoids and phenolic acids, which could be transformed from flavonoids by human intestinal microflora, on H. pylori growth has been studied [101] . Ponciretin, hesperetin, naringenin and diosmetin were active against this bacterium. Among them, ponciretin was the strongest growth inhibitor (MIC = 10 -20 µg/ml). In contrast, these compounds did hardly inhibit the urease activity of H. pylori.
Other flavonoids have been obtained from the licorice (Glycyrrhiza uralensis) root extract [102] . Licorice is a commonly used crude drug in Kampo medicine (traditional Chinese medicines modified in Japan). Initially, the extract of this type of plants has been the basis of anti-ulcer medicines. Among the constituents of these plants, glabridin and glabrene (Glycyrrhizaglabra), licochalcone A (G. inflata), licoricidin and licoisoflavone B (G. uralensis) showed inhibitory activities against the growth of H. pyloriin vitro. These flavonoids were also active on clarithromycin and amoxicillin resistant strains. From a methanol extract of G. uralensis, Fukai by NMR and mass spectrometry. These authors found that cirsilineol exhibited potent
anti-H. pylori activity (IC90 = 3.2 µg/ml) but weak activity against Escherichia coli and Salmonella enteritidis. Cirsimaritin was also active against H. pylori (6.3 µg/ml) but having activity on other microorganisms as well. Considering structural features of these compounds they propose that flavonoids with potent activities had mainly adjacent dimethoxy-groups, especially at positions 6 and 7, and simultaneously some hydroxyl groups in the molecule as cirsilineol and cirsimaritin. The targets for these compounds have not been yet identified.
Isoflavones isolated from the flowers and rhizomes of Pueraria thunbergiana (Leguminosae) were tested on the growth of H. pylori [28] . It was found that isoflavones glycosides did not affect the bacterial growth. In contrast, their aglycones, irisolidone, tectorigenin and genistein did so. Among them, irisolidone had the highest growth inhibitory activity against H. pylori (MIC = 12.5 -25 µg/ml. Genistein only weakly inhibited urease from H. pylori and a H+/K(+)-ATPase of rat stomach (IC50 = 0.43 and 0.89 mg/ml respectively).
Another studied flavonoid is luteolin (2-[3,4dihydroxy-phenyl]-5,7-dihydroxy-4H-1-benzopyran-4one) defined as a type of phytoestrogen which is present in many plants (family Combretaceae). In particular, the red bell pepper has been demonstrated to contain an abundance of luteolin [106] [107]. Chung et al., (2001) [108] demonstrated that this compound inhibited uncompetitively the H. pylori NAT enzyme previously mentioned. Luteolin has been previously reported to be able to inhibit the growth of different kinds of human cancer cell lines (lung, ovary, melanoma, gastric) [109] [110] [111] and also exhibit antimutagenic activity in the bay region of diol epoxides of polycyclic aromatic hydrocarbons [123] . In addition, it has been shown that inhibit the growth of Neisseria gonorrhoeae with a MIC = 12.5 µg/disk [112] .
Since in most cases the target for antimicrobial activity of flavonoids and polyphenols has not been described, recent works of Shin (2005) [124] and Yahiro et al., (2005) Traditional medicine in India has employed Glycyrrhiza glabra Linn, a plant belonging to a legume family (Fabaceae) that grow as small bushes in Asia, Australia, Europe and the Americas, in the treatment of peptic ulcer caused by H. pylori. Recently, Asha et al., (2013) [114] have done studies to evaluate the anti-H. pylori action of GutGard, a flavonoid-rich extract from Glycyrrhiza glabra in order to elucidate the possible mechanisms of its anti-H. pylori activity. By using Agar dilution and micro broth dilution methods, the MIC of GutGard against H. pylori was obtained. Glabridin, the main flavonoid present in GutGard presented a remarkable activity against H. pylori while glycyrrhizin did not show this activity even at 250 μg/ml concentration. In a protein synthesis assay, GutGard caused a significant time-dependent inhibition of protein synthesis as measured by 35 S-methionine incorporation into H. pylori ATCC 700392 strain. Additionally, GutGard showed a strong inhibitory effect on DNA gyrase and dihydrofolate reductase with IC50 values of 4.40 μg/ml and 3.33 μg/ml respectively. However, the extract did not show significant inhibition on the adhesion of H. pylori to human gastric mucosal cell line. These assays revealed that GutGard acts against H. pylori possibly by causing inhibition of protein synthesis, DNA gyrase and dihydrofolate reductase.
Coumarins
Recently, Sekiguchi et al., (2012) [115] have reported that auraptene, a compound present in citrus fruit such as grapefruit (Citrus paradici) and hassaku (Citrus hassaku) inhibit adhesion of H. pylori to gastric cells by interference with expression of CD74, which has been identified as a receptor which binds H. pylori urease [125] . After oral administration of auraptene to mice infected with H. pylori, colonization and gastritis as result of inflammatory responses in C57BL/6 mice were remarkably attenuated. Biochemical analyses revealed that auraptene inhibited H. pylori-induced expression and/or production of CD74, macrophage migration inhibitory factor, IL-1β, and TNF-α in gastric mucosa, together with serum MIP-2 (macrophage inhibitory protein-2).
Treatment with this coumarin during the pretreatment period was more effective than post-treatment. These results suggest that auraptene is able to reduce gastritis and carcinogenesis associated with H. pylori.
Caffeates
A recent study of Paracatu et al., (2014) [116] was focused on caffeic acid and their esters and the inhibition of reactive oxygen species (ROS) usually released by neutrophils activated by H. pylori and the bactericidal activity of these compounds. Ester derivatives have higher hydrophobicity which improved their efficiency as bactericidal compounds when tested on H. pylori and as inhibitors of ROS production. For instance, the MIC values for bactericidal activity decreased from 1000 µg/ml for caffeic acid to 250 µg/ml for butyl and heptylcaffeates. Also, caffeates caused higher inhibition of ROS, superoxide anion and hypochlorous acid release by activated neutrophils.
Njume et al. (2011) [65] studied the activity of both acetone and aqueous plant extracts and theysuggested that Sclerocarya birrea, a medicinal plant, contains at least two different anti-H. pylori components, reiterating the potential of this plant as a possible source of antimicrobial agents against H. pylori. The acetone crude extract generally exhibited a better antimicrobial potential than the aqueous extract. This can be attributed to the presence of many more active components in this extract as revealed in the TLC analysis.
Essential Oils
Essential oils, which are extracted from plants (e.g., leaves, peels), showed the growth inhibition of H. pylori in vitro [126] [127] and in vivo studies on mice [117] . Among 13 essential oils utilized in an in vitro study, lemongrass oil was utilized on in vivo study because of the lowest in vitro MIC value described. The density of H. pylori colonization in the mice stomach treated with lemongrass oil was significantly reduced compared with untreated mice [117] . Considerable work on naturally occurring H. pylori therapeutics has focused upon the truly lipoidal oils, which include short-, medium-, and long-chain fatty acids as well as monoglycerides; and polyunsaturated fatty acids (commonly referred as PUFAs).
Fish oil [118] , garlic oil [119] , and blackcurrant seed oil (rich in ω-3 and ω-6 unsaturated fatty acids) [128] [129] all have in vitro antibiotic activity against H. pylori. Fish oil showed activity against H. pylori in humans [130] . Evening Primrose oil (rich in ω-6 unsaturated linoleic acid) healed ulcers in rats [131] and consumption of fish oil is inversely associated with the prevalence of duodenal ulcer. Garlic oil has been assayed in a simulated gastric environment showing MIC and MBC values of 32.4 µg/ml [120] .
Numerous investigators have reported in vitro positive effects of specific polyunsaturated fatty acids against H. pylori [132] [133] [134] , but studies in humans have been controversial, with some studies showing anti-H. pylori activity and others showing none [135] . Anti-inflammatory activity has been reported [136] , as a protective feature against ulcer formation [137] , a reduced risk for development of atrophic gastritis [137] , and suppression of gastric acid secretion [8] . Shorter chain fatty acid with activity against H. pylori has only been demonstrated in vitro [137] .
Satureja bachtiarica Bunge is traditionally used as the antimicrobial agent. In a recent study, Falsafi et al., (2015) [121] evaluated the antibacterial activity of S. bachtiarica Bunge essential oil against 10 clinical isolates of H. pylori by disc diffusion and agar dilution methods. The chemical composition of this essential oil was revealed by GC (Gas Chromatography) and GC-MS (Gas Chromatography-Mass Spectrometry). Carvacrol (45.5%) and thymol (27.9%) were the primary constituents of oil, followed by p-cymene (4.4%), and γ-terpinene (4.0%). S. bachtiarica essential oil showed strong antibacterial activity against clinical isolates of H. pylori (17.6 ± 1.1 mm and 0.035 ± 0.13 μl/ml). Carvacrol, as the first main component, had a significant role in this effect, whereas, in the presence of thymol, the antibacterial effect of carvacrol was reduced.
Therefore, S. bachtiarica essential oil can be applied as an alternative agent for treatment of H. pylori infections. More studies would be required to better clarify its mechanism of action on H. pylori. A review by Gotteland et al., 2006 [139] discuss the use of probiotics to control gastric colonization by H. pylori.
Probiotics to Treat H. pylori Infections
It has been proposed that probiotics may control H. pylori infection considering that some of the Lactobacilli strains may survive in the acidic environment of the human stomach, remaining for some time in that niche. Some strains may produce antimicrobial products such as bacteriocins [140] [141] and other metabolic end products of lactic fermentation (lactic acid, acetic acid) promoting low pH and affecting growth the of pH sensitive bacteria [142] . Some Lactobacillus strains may compete with H. pylori for adherence to the epithelial cells.
In vitro studies of Chatterjee et al., (2003) [96] revealed that Lactobacillus acidophilus DDS-1J inhibits H. pylori growth at 1:1 and higher ratios, but further studies in animal models and humans are required to corroborate these findings in vivo and determine dose range and frequency of dosing.
As a consequence of therapy failure, an increase in the prevalence of antibiot-ic-resistant bacteria has arisen, which has led to the search for alternative therapies. Vitor and Vale (2011) [143] Over the past 8 years, 11 meta-analyses have been published assessing the efficacy of probiotics as adjuvants to cooperate with antibiotics for the eradication of H. pylori (Table 3 , see [150] ). All these studies found that the addition of a probiotic to the antibiotic regimen increased treatment efficacy, with an odds ratio ranging from 1.12 to 2.07. A network meta-analysis performed by Li et al., (2015) [151] came to a similar conclusion. Although probiotic treatment accounted for only a small part of their analyses, they used novel yet robust methodology allowing for indirect comparisons across treatments where a common comparator exists and found that the addition of a probiotic to standard 7-day triple therapy increases eradication rates significantly (OR, 1.14).
Demographic factors have been identified as possible predictors of probiotic efficacy, although with conflicting results. Wang et al., (2013) [152] found that, in children, adjuvant probiotics conferred no benefit (OR, 1.08 compared to OR, 2.22 for adults). Boltin et al., 2016 [150] found that studies supporting the use of probiotics in conjunction with antibiotics for the treatment of H. pylori infection. Nevertheless, the optimal probiotic species, dose and treatment duration has yet to be determined. Furthermore, the benefit conferred by a probiotic is likely related to efficacy of the antibiotic regimen chosen.
Final Comments
Nowadays, the prevalence and the emergence of bacterial antibiotic resistances are a very serious problem. Concordantly, the antimicrobial eradication success rate of H. pylori has been declining globally in recent years. For example, clarithromycin resistance, in particular, has been rapidly increased in many countries over the past decade, with rates as high as 30% in both Japan and Italy, 50% in China and 40% in Turkey; whereas resistance rates are much lower in Sweden and Taiwan, with a rate of approximately 15% (Thung et al., 2016). Moreover, to date, there is no large scale production of an effective vaccine against H. pylori available in the market (Talebi, 2016) for different reasons as previously and extensively been reviewed by Hongying et al., (2014) [153].
Ancestral folk medicine passed from mouth to mouth for many years and has been wisely applied by "Chamanes" and "Curanderos" in some cases. It has been globally proven by diverse aborigine populations that some natural products obtained from nature can be helpful to alleviate and fight gastrointestinal diseases caused by microorganisms. This knowledge traditionally transferred within these families has been useful to identify the source to isolate and purify new and effective compounds to control many diseases. With the technology available today we can elucidate how folk medicine actually works and understand how it has helped our ancestors for many decades to counteract or reduce disease symptoms since many years ago.
There is a conundrum of components detected in plant extracts that should be studied as potential substitutes or additives in the antibiotic therapy. There are plants and marine algae living in extreme habitats that are able to synthesize bizarre but useful antibacterial compounds to fight the increased number of antibiotic resistant strains.
However, the isolation and identification of such compounds responsible for the positive effect on eradication of diverse diseases must be accomplished to test the safety of them and understand their mechanisms of action.
Considering the present situation of a large variety of natural sources with antimicrobial activities further studies will be required to identify the most powerful and useful compounds and test them for toxicity and genotoxic effects on humans before use them to successfully eradicate H. pylori from the human stomach.
A comparative study of the antimicrobial activity of different products will be a must in order to use mixtures displaying synergism. Also, the synergism already described between some plant organic compounds and antibiotics could be a very effective alliance. It is also desirable that most of these new products should work in a specific way against pathogenic bacteria without affecting our normal microbiome.
At present, it is very difficult to compare efficacy among all these products pursuing the same objective against H. pylori. In the case of plant derivatives, when using a particular vegetal extract, the amount of active compound extracted will depend on the source, section or organ used as starting material for the isolation, as well as other parameters such as time taking for the extraction, appropriate solvent for the procedure and so on. Moreover, the existence of different H. pylori strains does make difficult to compare which extract is better than other. The use of a combination of agents or purified compounds with or without antibiotics could be a faster way to find out a rapid answer to improving the treatment against H. pylori. This combined strategy will make more difficult to allow emergence of resistant strains after a treatment with mixed compounds, due to the large chemical differences among these compounds and their biological and physical characteristics.
The intention of this revision was to describe potential alternatives for the treatment of H. pylori but due to the great diversity of compounds we cannot provide a clear and define comparative analysis of the different products with antimicrobial activity. In addition, a diet rich in foods having different natural activities anti-H. pylori may be an inexpensive but effective collaborator against the rise of antibiotic resistant strains. On the other hand, pharmaceutical companies would be more supportive of development of new drugs based on natural products.
Finally, it is required even more research studies to elucidate the mechanisms of action of these molecules, their synergisms, antagonisms and other pharmacological aspects.
